EGFR and glioblastoma: Conversely, the presence of peculiar molecular features (IDHwt-status associated with EGFR amplification, TERT mutation, or +7/−10 chromosome copy number changes) suffices for the definition of GBM, regardless of microscopical features (that is, even though the microscopical evaluation advocates for LGG).